Photo Credit: Kudryavtsev Pavel
Insights into Upcoming Psoriasis Session at the American Academy of Dermatology Annual Meeting 2025
The 2025 American Academy of Dermatology Annual (AAD) Meeting is scheduled for March 7, 2025, to March 11, 2025, in Orlando, Florida. The overall goals of this meeting are to encourage attendees to engage with experts in the field, connect with peers, and provide healthcare providers with the most current clinical information and advancements in diagnosing and treating various dermatological diseases and to expand provider knowledge and proficiency to aid in delivering quality healthcare to patients.
Below is a summary of scheduled sessions that will focus on the topic of psoriasis at the 2025 AAD Annual Meeting, including:
Inside Psoriasis: A Focus On Advanced, Targeted Systemic Therapy
- Date: Thursday, March 6
- A newsroom-style symposium that will concentrate on systemic psoriasis treatment. The overall goals of this program will be to promote participation from the audience and provide beneficial clinical expertise from distinguished faculty hosts and panelists who will discuss current advancements regarding clinical data, patient burden, health-related quality of life, and guidance on systemic treatment and encourage participants to share their perspectives on psoriasis and engage with fellow clinicians.
JAK Inhibitors: A New Frontier In Dermatology
- Date: Friday, March 7
- Janus kinase (JAK) inhibitors represent a revolutionary class of medication within the field of dermatology, presenting a unique and increasingly critical approach to treating an extensive array of inflammatory skin conditions.
- This presentation will examine the application of JAK inhibitors in the scope of dermatologic diseases, focusing on efficacy data and outcomes of clinical trials and case studies. Furthermore, a comprehensive assessment of the safety profile associated with JAK inhibitors will be presented.
- This session is geared toward dermatologists who specialize in the care of patients dealing with alopecia areata, atopic dermatitis, prurigo nodularis, pruritus, granuloma annulare, sarcoidosis, lichen planus, lupus, dermatomyositis, hidradenitis suppurativa, psoriasis, and vitiligo.
Nail Symposium
- Date: Friday, March 7
- This session will provide a comprehensive and current overview of the diagnosis and treatment of major nail disorders. The panel will include experts from around the globe who will provide information on the most current scientific evidence on onychomycosis, nail unit psoriasis, nail unit lichen planus, nail unit squamous cell carcinoma, nail unit melanoma, nail disorders in patients with skin of color, self-induced nail disorders, onychoscopy, and more.
Obesity-Related Inflammation & Psoriasis: A Conversation On The Interplay And What You Need To Know
- Date: Friday, March 7
- This session will provide information on the association between psoriasis, obesity, and inflammation and examine the epidemiology and impact of psoriasis and obesity. Panelists will also provide information on the challenges encountered in treating patients and provide practical methods for optimizing the delivery of comprehensive care.
Psoriasis: Modern Therapeutic Approaches
- Date: Saturday, March 8
- This comprehensive overview will provide the most recent advancements in the field of psoriasis and its treatment with a concentration on oral and biological therapies, managing mild-to-moderate psoriasis and addressing specific areas of concern, the value of early intervention strategies, the associated comorbidities of psoriasis, and the impact of clinical intervention on these comorbidities.
Inflammatory Skin Diseases: The Translational Revolution
- Date: Saturday, March 8
- During this symposium, experts will present information to expand knowledge about therapeutic developments for common inflammatory skin diseases encountered in daily practice and discuss the advancements in therapy to enhance patient outcomes and patient care. Topics that will be discussed include the swift development and testing of more targeted treatments for these diseases in both early and late-stage clinical trials, which are proving to be safer for long-term disease control than older, primarily immune suppressant therapies.
Psoriasis
- Date: Saturday, March 8
- This will be an engaging session concentrating on the latest advancements in psoriasis therapies for 2025. This session will provide significant insights into the evolving landscape of oral treatments, strategies for managing GPP and palmoplantar pustulosis, advancements in precision medicine, and updates on psoriatic arthritis. Additionally, information on topical therapies and effective management of psoriatic nail disease will also be presented.
- The session will also feature two dynamic debates: the first debate will explore whether dermatologists should play a role in managing obesity in psoriasis patients, while the second debate will compare oral therapies and biologics for moderate psoriasis.
The Patient’s Voice: Guiding the Path to Address Unmet Needs in Psoriasis
- Date: Saturday, March 8
- This symposium will examine the persistent challenges and gaps in care that patients with moderate to severe plaque psoriasis often encounter. The unmet needs of this patient population continue to create substantial barriers to care, ultimately affecting patient outcomes and overall experience.
- The symposium will discuss the value of understanding patients’ perspectives, the role of patient-centered treatment, and enhancing patient care and outcomes. Panelists will discuss current and future research initiatives in the field of psoriasis, with a focus on addressing the barriers to care that patients frequently encounter and offer practical measures to address them.
